Tokyo, Nov. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062762) titled 'The moderating role of pre-transplant steatotic liver disease in the association between psychological aspects of eating behavior and weight gain after liver transplantation: a cross-sectional study' on Nov. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - steatotic liver disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To identify the moderating effect of pre-transplant steatotic liver disease on the association between psychological aspects of eating behavior and weight gain after liver transplantation.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - (1) Patients who underwent liver transplantation at 18 years of age or older
(2) Liver transplant recipients who are between six months and five years post-transplant
(3) Individuals who can read and write Japanese
Key exclusion criteria - (1) Pregnant women
(2) Patients undergoing treatment for malignant tumors (other than skin cancer) or recurrent hepatocellular carcinoma after liver transplantation
(3) Patients awaiting liver transplantation
(4) Patients who underwent a re-transplant or multi-organ transplant
(5) Patients who are ineligible for study participation based on the judgment of doctors and researchers
Target Size - 180
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 09 Month 01 Day
Anticipated trial start date - 2026 Year 11 Month 16 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071856
Disclaimer: Curated by HT Syndication.
